FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma ...

FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma multiforme (GBM), a highly aggressive brain cancer - - Multiple U.S. clinical ...

Someone has to pay the cost of higher U.S. tariffs — and part of the cost finally appears to be falling on consumers. A key ...

There are mounting concerns over the quality of inflation and employment reports following budget and staffing cuts.

New inflation figures showed signs that President Trump’s tariffs are starting to have an impact on consumer prices. Overall ...

Guidance for Q3 2025 revenue ($31 million to $34 million) is consistent with the previous quarter’s Q2 guidance. Management shifted toward highlighting operational breakeven and margin improvement, ...

Discover why UNH's AI-driven cost-cutting and membership growth fuel double-digit revenue projections through 2025, despite ...

Core Energy Corp. reported improved financial and operational results for Q2 2025, marked by significantly increased uranium ...